LEOCLAN Co.,Ltd.

7681.T
Medical Distribution
2026/09/28 18:47 Updated
Market Cap: $37.6M (¥5.9B)
Stock Price: $6.34 (¥999)
Exchange Rate: 1 USD = ¥157.48

Notice on the Establishment of a Nomination and Remuneration Committee

The board resolves to establish a Nomination and Remuneration Committee. The committee will be composed of a majority of independent external directors and will serve as an advisory body to deliberate and report on matters such as appointment and dismissal of executives, appointment and removal of the CEO and executive directors, remuneration-related items, successor planning, and other important governance matters. The establishment date is October 1, 2026.

Importance:
Page Updated: September 15, 2026
IR Disclosure Date: September 14, 2026

Key Figures

  • Personnel composition: 3 or more members, majority independent external directors
  • Establishment date: 2026-10-1
  • Items included in the committee's roles: appointment and dismissal, remuneration, successor planning, and other important matters

AI要約

Section Heading

This notice states that at the board meeting held on September 14, 2026, the board resolved to establish a discretionary Nomination and Remuneration Committee as an advisory body. The committee's objective is to strengthen fairness, transparency, and objectivity in the appointment and remuneration procedures for directors and others, and to enhance corporate governance. The committee's roles include deliberation and reporting on the appointment and dismissal of directors, selection and removal of the representative director and senior executive officers, remuneration-related matters, successor planning, and other significant management matters. The committee will consist of three or more members, with the majority being independent external directors. The establishment date is October 1, 2026.

Section 2 Heading

This notice communicates to shareholders and the market the intention to enhance transparency in the decision-making process for management appointments and remuneration, representing an important governance measure aimed at improving transparency of management decisions and long-term corporate value. After establishment, the committee's recommendations are expected to be disclosed and reflected through the board, and it is anticipated that appropriate successor planning and remuneration framework improvements will progress.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

LEOCLAN Co.,Ltd.

Company overview · Stock price · Financial data · All IR

View company page →